15-DESMETHYL FK-506 AND 15,31-DESMETHYL FK-506 FROM HUMAN LIVER-MICROSOMES - ISOLATION, IDENTIFICATION (BY FAST-ATOM-BOMBARDMENT MASS-SPECTROMETRY AND NMR), AND EVALUATION OF IN-VITRO IMMUNOSUPPRESSIVE ACTIVITY
Gjj. Lhoest et al., 15-DESMETHYL FK-506 AND 15,31-DESMETHYL FK-506 FROM HUMAN LIVER-MICROSOMES - ISOLATION, IDENTIFICATION (BY FAST-ATOM-BOMBARDMENT MASS-SPECTROMETRY AND NMR), AND EVALUATION OF IN-VITRO IMMUNOSUPPRESSIVE ACTIVITY, Clinical chemistry, 40(5), 1994, pp. 740-744
15-Desmethyl FK-506 and 15,31-desmethyl FK-506 metabolites extracted f
rom incubated human liver microsomes were separated by normal and reve
rsed-phase HPLC. The metabolites were identified by fast atom bombardm
ent/mass spectrometry and nuclear magnetic resonance spectroscopy. The
in vitro 50% inhibitory concentration, tested against bidirectional m
ixed lymphocyte reactions, was 325 mg/L for 15,31-desmethyl FK-506 and
4 mg/L for 15-desmethyl FK-506, indicating that these products of FK-
506 demethylation retain in vitro immunosuppressive activity.